Environmental Health (Apr 2009)

Placental biomarkers of phthalate effects on mRNA transcription: application in epidemiologic research

  • Nelson Heather,
  • Thaker Harshwardhan M,
  • Whyatt Robin M,
  • Williams Paige L,
  • Hauser Russ,
  • Adibi Jennifer J,
  • Herrick Robert,
  • Bhat Hari K

DOI
https://doi.org/10.1186/1476-069X-8-20
Journal volume & issue
Vol. 8, no. 1
p. 20

Abstract

Read online

Abstract Background CYP19 and PPARγ are two genes expressed in the placental trophoblast that are important to placental function and are disrupted by phthalate exposure in other cell types. Measurement of the mRNA of these two genes in human placental tissue by quantitative real-time polymerase chain reaction (qPCR) offers a source of potential biomarkers for use in epidemiologic research. We report on methodologic challenges to be considered in study design. Methods We anonymously collected 10 full-term placentas and, for each, sampled placental villi at 12 sites in the chorionic plate representing the inner (closer to the cord insertion site) and outer regions. Each sample was analyzed for the expression of two candidate genes, aromatase (CYP19) and peroxisome proliferator activated receptor protein gamma (PPARγ) and three potential internal controls: cyclophilin (CYC), 18S rRNA (18S), and total RNA. Between and within placenta variability was estimated using variance component analysis. Associations of expression levels with sampling characteristics were estimated using mixed effects models. Results We identified large within-placenta variability in both transcripts (>90% of total variance) that was minimized to Conclusion qPCR-derived biomarkers of placental CYP19 and PPARγ gene expression show high within-placental variability. Sampling scheme, selection of an appropriate internal control and the timing of sample collection relative to delivery can be optimized to minimize within-placenta and other sources of underlying, non-etiologic variability.